MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Asymptomatic Cardiac Ischemia Pilot (ACIP) Study

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Myocardial Ischemia
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000478

Penicillin Prophylaxis in Sickle Cell Disease (PROPS)

Phase 3
Completed
Conditions
Hemoglobinopathies
Pneumonia
Anemia, Sickle Cell
Hematologic Diseases
Infection (S. Pneumoniae)
First Posted Date
1999-10-28
Last Posted Date
2016-03-25
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000585

Acute Respiratory Distress Syndrome Clinical Network (ARDSNet)

Phase 3
Completed
Conditions
Respiratory Distress Syndrome, Adult
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-03-23
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000579
Locations
🇺🇸

University of California, San Francisco, California, United States

🇺🇸

University of Colorado Health Sciences Center, Denver, Colorado, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

and more 18 locations

Harvard Atherosclerosis Reversibility Project (HARP)

Phase 2
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000461

Arterial Disease Multifactorial Intervention Trial (ADMIT)

Phase 3
Completed
Conditions
Heart Diseases
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Diabetes Mellitus
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000539

PREMIER: Lifestyle Interventions for Blood Pressure Control

Phase 3
Completed
Conditions
Hypertension
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000616

Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration

Phase 3
Completed
Conditions
Lung Diseases
Respiratory Distress Syndrome
First Posted Date
1999-10-28
Last Posted Date
2012-04-27
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000563

Cardiac Arrhythmia Pilot Study (CAPS)

Phase 2
Completed
Conditions
Arrhythmia
Cardiovascular Diseases
Heart Diseases
Ventricular Arrhythmia
First Posted Date
1999-10-28
Last Posted Date
2012-04-27
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000504

Stress Reduction & CVD Morbidity and Mortality in Blacks

Phase 2
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2008-07-24
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000537

Women's Angiographic Vitamin and Estrogen Trial (WAVE)

Phase 3
Completed
Conditions
Coronary Arteriosclerosis
Myocardial Ischemia
Postmenopause
Cardiovascular Diseases
Coronary Disease
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000555
© Copyright 2025. All Rights Reserved by MedPath